Chester County News and Community Website
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced a commercial partnership with Alleviant Health Centers, a network of full-service mental health clinics that currently operates five locations in Arkansas …
Neuronetics Partners With Alleviant Health Centers Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced this week that they recently received 510(k) clearance on their MT Cap technology for NeuroStar® Advanced Therapy for Mental Health. A limited …
Neuronetics Recieves 510(k) Clearance of MT Cap Technology for NeuroStar Advanced Therapy for Mental Health Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) and River Region Psychiatry Associates (RRPA) this week announced a partnership agreement under which Neuronetics will be the exclusive supplier of transcranial magnetic …
Neuronetics and River Region Psychiatry Announce Exclusive Partnership Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced a recent commercial agreement with Success TMS in which Success TMS will exclusively utilize Neuronetics’ platform, NeuroStar Advanced Therapy for Mental Health, …
Neuronetics Announces Commercial Agreement with Success TMS Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar® Advanced Therapy for Mental Health than with TMS treatments that claim deeper …
New Data Highlights NeuroStar Advanced Therapy for Mental Health Safety Over H-Coil TMS Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar® Advanced Therapy for Mental Health than with TMS treatments that claim deeper …
New Data Highlights NeuroStar Advanced Therapy for Mental Health Safety Over H-Coil TMS Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe …
FDA Approves First-of-Its-Kind Stroke Rehabilitation System Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX: HSM) announced it will participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics, which will …
Helius Medical Technologies Selected to Receive the “Pioneer in Technology Award” Read More
Parkinson’s Disease (PD) impacts up to one in 15 individuals in the United States. People with PD often experience symptoms that impact their movement, like tremors, shuffling feet while walking, …
For Parkinson’s Disease Patients, Effective Implantable Therapy Can Now Last Up to 15 Years Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate …
FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients Read More